Improving prevention of blood clots in cancer patients
An Intervention to Reduce Cancer Associated Thrombosis Through Improved Prophylaxis
This study is looking for ways to help cancer patients avoid dangerous blood clots by using blood-thinning medications more effectively, so they can feel safer during their treatment.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10906164 on NIH RePORTER |
What this research studies
This research focuses on enhancing the prevention of cancer-associated thrombosis (CAT) through better use of anticoagulant therapies in patients undergoing cancer treatment. The principal investigator, Dr. Jordan Schaefer, will receive training in qualitative research and implementation science to develop effective strategies for increasing the use of anticoagulants in community healthcare settings. The goal is to identify and implement interventions that can improve prophylaxis rates for patients at high risk of developing blood clots due to cancer. By addressing the barriers to effective treatment, this research aims to save lives and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are at high risk for developing blood clots and are receiving systemic cancer therapy.
Not a fit: Patients who are not undergoing cancer treatment or those who do not have a high risk for thrombosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of blood clots in cancer patients, leading to improved survival rates and quality of life.
How similar studies have performed: Previous research has shown success in increasing prophylaxis rates in academic medical centers, indicating that similar approaches may be effective in community settings.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Schaefer, Jordan — University of Michigan at Ann Arbor
- Study coordinator: Schaefer, Jordan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.